Cite
HARVARD Citation
Clamp, A. et al. (2019). Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial. Lancet. 394 (10214), pp. 2084-2095. [Online].